In vitro research use only Not for human or animal use peptides Sermorelin is a synthetic analogue of the first 29 amino acids of endogenous GHRH, studied in growth hormone axis research
Studied in preclinical metabolic research
REDUCE CHRONIC CONDITIONS By targeting both weight loss and blood sugar control, Tirzepatide helps reduce the risk of chronic conditions such as cardiovascular disease, diabetes, and other obesity-related health complications, promoting lasting wellness
These include kidney disease, obstructive sleep apnea, and diabetic retinopathy, which can be impacted by changes in blood sugar levels
GLP-1 medications help with weight loss by: Suppressing Hunger Increasing Feelings of Fullness Slowing Down Digestion, which Results in Reduced Calorie Intake This makes GLP-1 weight loss treatments a popular and effective option for people struggling with obesity or metabolic conditions
Real-World Effectiveness and Safety of Dapagliflozin Therapy Added to a GLP1 Receptor Agonist in Patients with Type 2 Diabetes